Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02733120 · ClinicalTrials.gov registry record · NA
Metabolic Processes in Adults and Adolescents With Autism Spectrum Disorder
A NA study, sponsored by Texas A&M University.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT02733120 is a NA study that has completed, run by Texas A&M University. The registered enrollment target is 40 participants.
The verdict
NCT02733120, a NA study, has completed, sponsored by Texas A&M University.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
The objective of this study is to gain preliminary information and knowledge on metabolic profile in ASD. The benefit of this study will be to expand our insight of the potential relationship in metabolic processes and neuropsychological functions in ASD. For example, based on the obtained data of the study we can determine whether there is a link between the tryptophan pathway and cognitive functions in autism. The project is based on a systematic and multidisciplinary approach using tracers for delineating the mechanism by which the metabolism of amino acids like TRP is involved in affective and cognitive functions in ASD. Using an innovative approach to the evaluation of amino acids has not been used in adults with ASD. In addition, the obtained data of the study holds promise to develop specific markers (metabolic and/or neuropsychological) for guiding the identification those individuals with increased risk of developing mood disturbances or cognitive impairment, and for predicting the therapeutic effect of a specific nutritional interventions in subjects with ASD.
Interventions
- OTHER stable isotope infusion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2015-12-03 |
| Est. Completion | 2017-10-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02733120
The ClinicalTrials.gov registry entry for NCT02733120 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Texas A&M University, which has 95 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which stable isotope infusion is the first listed.
NCT02733120 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02733120 about?
NCT02733120 is a clinical study titled "Metabolic Processes in Adults and Adolescents With Autism Spectrum Disorder". The objective of this study is to gain preliminary information and knowledge on metabolic profile in ASD. The benefit of this study will be to expand our insight of the potential relationship in metabolic processes and neuropsychological functions in ASD. For example, based on the obtained data of t...
What is the current status of trial NCT02733120?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2015-12-03. Estimated completion is 2017-10-30.
What interventions are being tested in trial NCT02733120?
The interventions under investigation include: stable isotope infusion (OTHER).
Who is sponsoring clinical trial NCT02733120?
This trial is sponsored by Texas A&M University, which has 95 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.